» Articles » PMID: 20180669

Examination of the Inventory of Drug Use Consequences with Individuals with Serious and Persistent Mental Illness and Co-occurring Substance Use Disorders

Overview
Publisher Informa Healthcare
Specialty Psychiatry
Date 2010 Feb 26
PMID 20180669
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The Inventory of Drug Use Consequences (InDUC) ( [1] ) is a 50-item measure that evaluates lifetime and recent consequences of substance use.

Objectives: This study examined the psychometric properties of a modified version of the Inventory of Drug Use Consequences (InDUC-M) in individuals with serious and persistent mental illness (SPMI) and co-occurring substance use disorders (SUDs).

Methods: We examined self-reported consequences in the sample, evaluated internal consistency, identified items for a brief form of the InDUC-M, and explored relationships with indicators of substance use severity.

Results: InDUC-M Lifetime and Recent subscales showed good internal consistency and were related to other measures of substance use and problems. A brief version of the InDUC-M Recent (SIP-M) showed excellent internal consistency and was highly correlated with both Lifetime and Recent subscales.

Conclusion: The InDUC-M and the SIP-M performed well in individuals with SPMI and SUDs.

Conclusion And Scientific Significance: Overall, these findings are a useful first step in determining the utility of the InDUC-M in people with SPMI and SUDs.

Citing Articles

Serious mental illness and negative substance use consequences among adults on probation.

Rossheim M, Livingston M, Lerch J, Taxman F, Walters S Health Justice. 2018; 6(1):6.

PMID: 29569076 PMC: 5864578. DOI: 10.1186/s40352-018-0064-7.


Internalized stigma as an independent risk factor for substance use problems among primary care patients: Rationale and preliminary support.

Kulesza M, Watkins K, Ober A, Osilla K, Ewing B Drug Alcohol Depend. 2017; 180:52-55.

PMID: 28869858 PMC: 5648632. DOI: 10.1016/j.drugalcdep.2017.08.002.


Validation of the revised Problems Assessment for Substance Using Psychiatric Patients.

Vincent P, Bradizza C, Carey K, Maisto S, Stasiewicz P, Connors G Addict Behav. 2011; 36(5):494-501.

PMID: 21330064 PMC: 3060568. DOI: 10.1016/j.addbeh.2011.01.024.

References
1.
Tonigan J, Miller W . The inventory of drug use consequences (InDUC): test-retest stability and sensitivity to detect change. Psychol Addict Behav. 2002; 16(2):165-8. View

2.
Lehman A, Myers C, Dixon L, Johnson J . Detection of substance use disorders among psychiatric inpatients. J Nerv Ment Dis. 1996; 184(4):228-33. DOI: 10.1097/00005053-199604000-00005. View

3.
Nidecker M, DiClemente C, Bennett M, Bellack A . Application of the Transtheoretical Model of change: psychometric properties of leading measures in patients with co-occurring drug abuse and severe mental illness. Addict Behav. 2008; 33(8):1021-30. PMC: 2583262. DOI: 10.1016/j.addbeh.2008.03.012. View

4.
Spitzer R, Williams J, GIBBON M, First M . The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry. 1992; 49(8):624-9. DOI: 10.1001/archpsyc.1992.01820080032005. View

5.
Mueser K, Yarnold P, Levinson D, Singh H, Bellack A, Kee K . Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophr Bull. 1990; 16(1):31-56. DOI: 10.1093/schbul/16.1.31. View